Shanghai, China, September 6, 2012 - PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, this week officially opened its new Greater China headquarters and celebrated the 75th anniversary of the Company’s brand and growth investments in China. Governmental leaders, key customer representatives and PerkinElmer’s chairman and chief executive officer, participated in a ceremony held at the new office building in Zhangjiang Hi-tech Park, Shanghai.
“As we commemorate this important milestone, we are proud to recognize our rich history of enhancing the quality of life throughout China for the better – from healthier newborns, better cures and treatments, to safer food and a cleaner environment,” said Robert F. Friel, chairman and chief executive officer of PerkinElmer. “The opening of our new Greater China headquarters personifies our continued commitment to our customers and to our vision OF advancing the longevity and quality of life for the people of China.”
As the Company commemorates its 75th anniversary as a brand, it is also increasing its investment in China with a new Customer Knowledge Center (CKC), a Global Software Research & Development (R&D) Team and a Global Application Development Center, based out of the new Shanghai headquarters.
Mr. Nam-Hoon Kim, vice president, Asia Pacific and general manager, China at PerkinElmer, said, “We are excited about our recent innovation investments and customer-focused initiatives in China. In particular, the establishment of the new Customer Knowledge Center will help to further address the needs of our Chinese customers while improving the health and safety of the Chinese people and the environment.”
PerkinElmer has achieved another significant milestone in China. PerkinElmer’s new diagnostics research and development and manufacturing facility based in Taicang, Suzhou will officially begin production in September. The facility recently passed the Good Manufacturing Practices (GMP) certification conducted by the State Food and Drug Administration (SFDA). The site, which will produce high-quality diagnostic reagents and testing instruments, will be mainly oriented to the emerging markets and is expected to become one of the most significant and largest PerkinElmer R&D and manufacturing sites worldwide.
Integral to its mission and beliefs, PerkinElmer shares common goals with the Chinese people, including ensuring neonatal health, detecting disease earlier, developing new and better drugs faster, improving air and water quality, and increasing the efficiency and amount of renewable energies.
PerkinElmer, Inc. is a global leader in improving the health and safety of people and the environment. The Company reported revenue of approximately USD1.9 billion in 2011, has approximate 7,000 employees serving the customers in more than 150 countries, and is a member of Standard & Poor’s (S&P) 500 Index. For more information, please make a phone call on 1-877-PKI-NYSE or visit our Website www.perkinelmer.com.
# # # #